VivoSeq
Other

Intrauterine Adhesions

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Intrauterine Adhesions is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

11

clinical trials

Unknown status6 · 55%
Recruiting2 · 18%
Completed2 · 18%
Active, not recruiting1 · 9%

Trial Activity

11 trials

Intrauterine Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions
Unknown status··N/A·NCT04975373·160 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)